Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Psilocybin-assisted Treatment for Cannabis Use Disorder
Johns Hopkins University
An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)
Sheppard Pratt Health System
Evaluation of Psilocybin-Assisted Psychotherapy in Treating Severe Depression in Patients With PTSD
Apex Labs Ltd.
PRoMiSS: Psilocybin and the Role of Music in Set and Setting
Johns Hopkins University
Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs
University College, London
Psilocybin-assisted CBT for Depression
University of California, Los Angeles
Does Psilocybin Require Psychedelic Effects to Treat Depression?
Centre for Addiction and Mental Health
Bioavailability Study of Psilocybin in Normal Adults
University of Wisconsin, Madison
Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study
McMaster University
A Community of Practice Program With Psilocybin-assisted Therapy for End-of-Life Patients
The Roots to Thrive Society for Psychedelic Therapy
Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder
New York State Psychiatric Institute
Psilocybin for Major Depressive Disorder (MDD)
Usona Institute
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
University of Colorado, Denver
Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN
Unity Health Toronto
NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy
M.D. Anderson Cancer Center
The Neurobiological Effect of 5-HT2AR Modulation
Gitte Moos Knudsen
Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action
Imperial College London
Psychopharmacology of Psilocybin in Cancer Patients
Johns Hopkins University
Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain
University of California, Berkeley
Exploratory Study of Low Dose Psilocybin
University of Alabama at Birmingham
Psilocybin-Assisted Therapy for Intergenerational Trauma
Rachel Yehuda
Phase 1b Study in Patients With Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)
Beckley Psytech Limited
Low-Income Group Psilocybin Assisted Therapy for Depression
Matthew Hicks
Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
Yale University
Comparative Acute Effects of LSD, Psilocybin and Mescaline
University Hospital, Basel, Switzerland
Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
Johns Hopkins University
Investigation to Understand and Optimize Psilocybin
Charles Raison
Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence
University of New Mexico
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
Cybin IRL Limited
PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related Burnout
University of Utah
Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment
Centre for Addiction and Mental Health
Psilocybin in Adults With and Without Autism Spectrum Disorder
King's College London
Psilocybin and Spiritual Practice
Johns Hopkins University
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Cybin IRL Limited
Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia
Kevin Boehnke
Personality and Drug Use
Psychedelic Data Society
Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter
NYU Langone Health
Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder
Halucenex Life Sciences Inc.
Mindfulness-based Psilocybin Therapy for PTSD
Anthony P King
The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training
Felix Mueller
Salivary Oxytocin as a Biomarker of Psychedelic Treatment
University of Geneva, Switzerland
PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder
Usona Institute
Psilocybin for Treatment-Resistant Depression
University of Colorado, Denver
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
University of Iowa
Effects of Psilocybin in Major Depressive Disorder
Johns Hopkins University
The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression
COMPASS Pathways
ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression
Eleusis Therapeutics
Repeat Dosing of Psilocybin in Migraine Headache
Yale University
Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms
Imperial College London
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
M.D. Anderson Cancer Center
Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)
Centre for Addiction and Mental Health
The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals
NYU Langone Health
Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects
University Hospital, Basel, Switzerland
Precision Functional Brain Mapping in Psilocybin
Washington University School of Medicine
Microdosing Psychedelics to Improve Mood
Rotem Petranker
Psilocybin With Intracranial Neural Sensing
Joshua Woolley, MD, PhD
Psilocybin for Treatment of OCD-2
Francisco A Moreno
The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
Maryland Oncology Hematology, PA
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer
University Health Network, Toronto
Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study
Imperial College London
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
Icahn School of Medicine at Mount Sinai
Psilocybin for Opioid Use Disorder (OUD)
NYU Langone Health
Comparing the Effects of Psilocin and Psilocybin in Healthy Adults
University of California, San Francisco
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD
Massachusetts General Hospital
Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought
Johns Hopkins University
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
VA Office of Research and Development
The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density
Section for Affective Disorders; Northern Stockholm Psychiatry
The RECAP2 Study: Midazolam and Psilocybin
University of Wisconsin, Madison
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
The University of Texas Health Science Center, Houston
Characterization of Altered Waking States of Consciousness in Healthy Humans
University of Zurich
Psilocybin as a Treatment for Chronic Pain in Smokers
Yale University
Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD
Centre for Addiction and Mental Health
Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study
Oregon Health and Science University
Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain
Emory University
Consciousness, Psilocybin, and Well-Being
University of Wisconsin, Madison
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
Johns Hopkins University
A Study of Psilocybin for Major Depressive Disorder (MDD)
Usona Institute
Effects of Psilocybin in Concussion Headache
Yale University
Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy Subjects
University Hospital, Basel, Switzerland
Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)
Johns Hopkins University
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
Yale University
Psilocybin-Assisted Therapy in Treatment-Resistant Depression
University of North Carolina, Chapel Hill
Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication
University of British Columbia
Pilot RECAP Study in Healthy Volunteers
University of Wisconsin, Madison
Psilocybin for Hospitalized Patients with Treatment-resistant Depression
University Hospital, Ghent
Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids
Roswell Park Cancer Institute
Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
Johns Hopkins University
Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD
Unity Health Toronto
Frontline Clinician Psilocybin Study
University of Washington
The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation
Sheppard Pratt Health System
Psilocybin-assisted Interpersonal Therapy for Depression
University of Otago
Psilocybin-Assisted Physical Therapy in Chronic Low Back Pain
Yale University
Psilocybin-Assisted Psychotherapy in Treating Irritable Bowel Syndrome (IBS)
NYU Langone Health
The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function
Manoj Doss
Psilocybin on Brain Mechanisms of Motivation in OUD
Anna Rose Childress, Ph.D.
Psilocybin-facilitated Treatment for Cocaine Use
University of Alabama at Birmingham
The ENHANCE Study: taVNS and Psilocybin
University of Wisconsin, Madison
Safety Profile of Psilocybin for Cocaine Use Disorder
University of California, Los Angeles
Psilocybin Therapy for Chronic Low Back Pain
Joshua Woolley, MD, PhD
Psilocybin-Assisted Therapy for Physician Well-Being and Burnout
University of California, San Diego
More trials available. Refine your search to see specific results.
How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
Read the trial details, eligibility criteria, and what participation involves.
Reach out to the study team using the contact information provided.
Complete the screening process to determine if you're eligible.